Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid in Calcific Aortic Valve Disease
NCT05861648Phase 2Not yet recruiting
- Start
- Jul 2023
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of folic acid in calcific aortic valve disease (CAVD), aortic valve stenosis. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
folic acid
03
Conditions
calcific aortic valve disease (CAVD)aortic valve stenosis
Beyond the preview
Go deeper on NCT05861648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05861648.